Cargando…
Asthma-associated risk for COVID-19 development
The newly described severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for a pandemic (coronavirus disease 2019 [COVID-19]). It is now well established that certain comorbidities define high-risk patients. They include hypertension, diabetes, and coronary artery disease. In...
Autores principales: | Skevaki, Chrysanthi, Karsonova, Antonina, Karaulov, Alexander, Xie, Min, Renz, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834224/ https://www.ncbi.nlm.nih.gov/pubmed/33002516 http://dx.doi.org/10.1016/j.jaci.2020.09.017 |
Ejemplares similares
-
SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship
por: Skevaki, Chrysanthi, et al.
Publicado: (2021) -
Comorbidity defines asthmatic patients' risk of COVID-19 hospitalization: A global perspective
por: Skevaki, Chrysanthi, et al.
Publicado: (2023) -
Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
por: Pusch, Emanuel, et al.
Publicado: (2018) -
Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus
por: Skevaki, Chrysanthi, et al.
Publicado: (2020) -
Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
por: Pusch, Emanuel, et al.
Publicado: (2018)